Philip A. Carpino - Concepedia

Author

Philip A. Carpino

Also Known As

Carpino, P.A., Carpino, Philip A., P A Carpino, P. A. CARPINO, P. CARPINO, Philip A Carpino, Philip A. Carpino, Philip Carpino, Philip A. Carpino, Xiaohe Wang

Publications

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Tufts Medical Center University of Washington Harvard University

About

Philip A. Carpino is an author at Pfizer (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	26	1.1K
2	Natural Sciences	15	17	777
3	Engineering	4	4	281
4	Health Sciences	1	1	22
5	Public Health	1	1	11

Philip A. Carpino

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms Matthew F. Calabrese, Francis Rajamohan, Melissa S. Harris, Structure Opposite PolesMolecular PhysiologySignal TransductionBiochemistrySignaling Pathway	2014	179
Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience Hassan Rastegar, Griffin Boll, Ethan J. Rowin, Annals of Cardiothoracic Surgery	2017	116
Enantiospecific total synthesis of pseudopterosins A and E E. J. Corey, Philip A. Carpino Journal of the American Chemical Society BiosynthesisBioorganic ChemistryMolecular SciencesBiochemistryPseudopterosins A	1989	101
A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation Donna N. Petersen, Julie A. Hawkins, Wanida Ruangsiriluk, Cell chemical biology Pcsk9 TargetsProtein FunctionSignal TransductionSmall-molecule Anti-secretagogueProtein Biosynthesis	2016	95
A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification Whitney M. Nolte, Jean‐Philippe Fortin, Benjamin D. Stevens, Nature Chemical Biology Molecular PharmacologyBiochemistryFunctional SelectivityMedicineG Protein-coupled Receptor	2014	85
Allylic selenides in organic synthesis: new methods for the synthesis of allylic amines Regan G. Shea, Jeffrey N. Fitzner, John E. Fankhauser, The Journal of Organic Chemistry EngineeringNatural SciencesAllylic SelenidesDiversity-oriented SynthesisAllylic Amines	1986	84
Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2) Kentaro Futatsugi, Daniel W. Kung, Suvi T. M. Orr, Journal of Medicinal Chemistry Combinatorial ChemistryLipid AnalysisMedicinal ChemistryBioorganic ChemistryLipid Synthesis	2015	80
New approaches to the synthesis of trans-alkene isosteres of dipeptides Andreas Spaltenstein, Philip A. Carpino, Fumio Miyake, The Journal of Organic Chemistry Bioorganic ChemistryEngineeringNew ApproachesAltmetric Attention ScoreOrganic Chemistry	1987	75
Discovery of 1-[9-(4-Chlorophenyl)-8-(2-chlorophenyl)-9<i>H</i>-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic Acid Amide Hydrochloride (CP-945,598), a Novel, Potent, and Selective Cannabinoid Type 1 Receptor Antagonist David A. Griffith, John R. Hadcock, Shawn C. Black, Journal of Medicinal Chemistry	2008	62
Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase. Jeremy C. Parker, Maria A. VanVolkenburg, Carolyn B. Levy, Diabetes Glucose-6-phosphate TranslocaseExperimental PharmacologyInsulin SignalingMetabolic SyndromeGlycogen Content	1998	57

Page 1